Bristol-Myers Squibb stock slips despite earnings beat
In the fast-paced world of finance, where every tick of the stock market can send ripples across the globe, Bristol-Myers Squibb, a renowned pharmaceutical giant, recently found itself in a paradoxical situation. Despite boasting robust earnings figures, the company’s stock witnessed an unexpected slip, leaving investors scratching their heads and analysts pondering the underlying reasons behind this perplexing market response. On the morning of April 22, 2024, Bristol-Myers Squibb (BMS) released its much-anticipated quarterly earnings report, unveiling a set of …